Article
ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema.
Pulmonary pharmacology & therapeutics - 1 Feb 2018
Nojiri Masafumi, Mizuno Shiro, Nishiki Kazuaki, Kato Ryo, Nakagawa Ken, Oikawa Taku, Iguchi Masaharu, Osanai Kazuhiro, Ishizaki Takeshi, Toga Hirohisa
Abstract excerpt
BACKGROUND: Genetic variation in the β2-adrenergic receptor (ADRB2) gene has been thought to have an important role in the differential response to β2-agonist therapy for asthma. However, previous studies have shown little evidence for an association between these ADRB2 variants and the bronchial dilator response (BDR) in chronic obstructive pulmonary disease (COPD) patients. This discrepancy could be explained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
